Pharmacy Retail Market Synopsis

The Global Pharmacy Retail Market size was reasonably estimated to be approximately USD 1.14 Trillion in 2023 and is poised to generate revenue of over USD 1.70 Trillion by the end of 2032, projecting a CAGR of around 4.5% from 2024 to 2032.

Pharmacy Retail is also known as community pharmacies. The retail community pharmacy refers to a chain or independent pharmacy that is authorized by the State to supply drugs to the general public at retail pricing. For convenience, these pharmacies are frequently dispersed across the community.  A Pharmacy Store is a retail shop that gives prescribed drugs, among other products. At the drug store, a druggist oversees the fulfillment of clinical prescriptions and is available to recommend their offerings of over-the-counter tablets. A regular pharmacy might be in the business area of a network. Every clinic must have a scientific store for obtaining, stocking, and dispensing tablets and medicines to diverse sections. Stores are described as sub-business enterprise in any hospitals where substances acquired are held in abeyance till inspected, accepted, and stocked. A shop should have a well-known specification of substances and the store procured the medication on behalf of the branch for an ordinary drift of material, the condition of the storage needs to be proper.

• Retail pharmacies handle different prescription and over-the-counter medicines for treating diseases. Retail pharmacies deal with a range of prescription and OTC drugs for treating common ailments. Retail pharmacies sell a variety of products, including allergy medications, drugs to lower blood pressure, antibiotics, and cold and flu treatments. Retail pharmacists are able to respond to queries, guide patients through symptoms, and provide advice on how to minimize adverse effects and prescription interactions.
• The rise incidence rate of mental disorders like anxiety, panic disorders, and insomnia boost the market growth. For instance, according to the World Health Organization, in 2019, 1 in every 8 people or 970 million all around the world were living with mental disorders like depressive disorders, and anxiety. Such factors drive the growth of the pharmacy retail market.

The Pharmacy Retail Market Trend Analysis

Increasing Prevalence Of Chronic Diseases Around The World

• The rising prevalence of chronic diseases leading to longer hospital admission is driving the market growth. The retail pharmacy provides branded and generic medicines with or without a prescription. With the increase in the geriatric population worldwide, various geriatric disorders also increase, which is excepted a driving factor of the market expansion. For instance, according to the World Health Organization, it is estimated at 2030 there will be 34 nations with over 20% population above 65 years.
• Moreover, an increasing number of sports injuries drives the market growth.  Nowadays rapid adoption of automation technologies like pharmacy robots, dispensing, and packing system boosts the market growth.
• Increasing the number of diabetes patients is expected to witness market growth due to patients with type 1 diabetes making little or no insulin and requiring daily insulin treatment to control and manage blood sugar levels.

Rising Demand For E-Commerce Sites

• In addition to prescriptions, retail pharmacies also offer vaccination services and healthcare services, which boosts the market growth. For example, CVS Health offers a variety of health management programs, such as a diabetes program to its 1.4 million customers, chronic kidney disease (CKD) care to more than 7.5 million members, and an oncology care program to more than 125 provider systems. 2020.  ePharmacy is excepted to be the fastest-growing segment during the forecast period.
• The introduction and spread of pharmacy delivery are one of the biggest shifts.  Additionally, the key players developed apps for prescription delivery service purposes where patients can share their prescriptions and medicines can be delivered to their doorstep. The increasing healthcare infrastructure and the upsurge in the development of pharmacies and wellness stores drive the pharmacy retail market growth during the forecast period.
• During the covid-19 pandemic the online pharmacy segment boosts the retail pharmacy market growth. During the covid-19 the visit to traditional pharmacy stores decreased. However, the need or demand for medicines has increased and hence people rely on e-commerce pharmacy retail services.

Segmentation Analysis of The Pharmacy Retail Market

Pharmacy Retail market segments cover the Drug Type and Distribution Channels. By Type, the Prescription Drugs segment is Anticipated to Dominate the Market Over the Forecast period.

• Increasing surgeries around the world driving the growth of the market during the forecast period. For instance, according to the National library of medicine, 310 million major surgeries are performed each year around the world and around 40 to 50 million in the USA and 20 million in Europe. Henceforth, the number of hospitalized people increases as a result of the prescription drugs segment driving the market growth in the upcoming years.
• The United Nations estimates that there are more than 703 million persons worldwide who are over 65. By 2050, this is anticipated to reach 1.5 billion. The need for prescription medications for treatments of oncology, diabetes, cardiovascular disease, respiratory diseases, antibiotic resistance, and blood disorders is growing. The increasing number of prescriptions in the United State drives the market growth. For instance, according to Statista, the total number of retail prescriptions was filled annually in the United States in 2019, and 4.38 billion retail prescriptions will be filled throughout the United States. The number is increasing year by year in the United State.

Regional Analysis of The Pharmacy Retail Market

North America is Expected to Dominate the Market Over the Forecast period.

• Due to the presence of major key players, CVS Health, Walgreens Boots Alliance, and other drives the market growth in this region. Increasing respiratory diseases like chronic obstructive pulmonary disease and asthma that required more medicines drive the market growth.  For instance, according to the asthma and allergic foundation of America, there are approximately 25 million people in the United State have asthma. This equals about 1 in 13 people. So, increased demand for medicine for asthmatic patients drives the pharmacy retail market growth.
• The raising awareness of various respiratory diseases, a paradigm shift in consumer behavior towards organized players who will provide high-quality drugs, high healthcare spending, and a well-established healthcare sector in North America dominates the pharmacy retail market. A rise in the investment in R&D by key players and an increase in the prevalence of cardiovascular and oncology diseases around the region are driving factors for the growth of the market. Moreover, in North America increase in various diseases like cancer, obesity, and cardiovascular problems increases the market share of pharmacy retail.

Covid-19 Impact Analysis On Pharmacy Retail Market

• Covid-19 hampers the growth of many sectors. During the covid-19 pandemic situation, many businesses and local stores were closed. Covid-19 has also affected the healthcare sector. However, during this pandemic, a large population is preferring online pharmacies to purchase medicine. Henceforth many retail pharmacies offer online services to dispense medicine to patients.
• During the period of Covid -19 the demand for online pharmacies was increasing across all the regions, hence there was a rapid increase in the adoption of online services, in the healthcare sector triggering the growth of the market during the pandemic. For instance, according to Statista, during the march 2020 survey of consumers in the United States, they were likely to purchase prescription and over-the-counter medicines online. OTC healthcare sales have increased significantly during the coronavirus pandemic situation.  
• Providing this high level of accessibility allow pharmacies to continue to service their current customer base throughout the pandemic, as well as reach new customers that may usually not purchase from the pharmacy due to restriction, but now can because of pharmacy delivery. Moreover, advancements in technology made in the supply chain such as retail stores, e-commerce, convenience stores, and customer touch points have left a considerable positive impact on the growth of the pharmacy retail market in the upcoming years.

Top Key Players Covered in The Pharmacy Retail Market

• CVS Health(US)
• Albertsons Companies (US)
• Ahold Delhaize (Netherlands)
• The Jean Coutu Group (PJC) Inc (Canada)
• Walgreens Boots Alliance, Inc (US)
• Wellness Forever Pharmacy (India)
• Dirk Rossmann GmbH (Germany)
• Rite Aid Corp (US)
• MedPlus Health Services Private Limited (India), and Other Major Players

Key Industry Developments in the Pharmacy Retail Market

• In February 2023, PharmEasy, another leading online pharmacy, acquired Akara, a digital healthcare platform focused on chronic disease management, for $185 million. This acquisition strengthens PharmEasy's offerings in chronic care and expands its reach into Tier 2 and Tier 3 cities.
• In May 2023, Tata 1mg, a leading online pharmacy, acquired MedPlus, a major brick-and-mortar pharmacy chain, for a reported $700 million. This marks the largest consolidation in the Indian pharmacy retail market and is expected to create a dominant player with a strong omnichannel presence.
• In June 2023, Reliance Retail, a major retail conglomerate, entered the pharmacy market with the launch of JioHealth, an online pharmacy platform. JioHealth leverages Reliance Retail's vast network and offers competitive pricing to attract customers.
• In July 2023, Amazon India partnered with Apollo Pharmacy to offer prescription drug delivery through its Prime membership program. This partnership provides Prime members with convenient access to a wide range of medications.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Drug Type
 3.2 By Distribution Channels

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Pharmacy Retail Market by Drug Type
 5.1 Pharmacy Retail Market Overview Snapshot and Growth Engine
 5.2 Pharmacy Retail Market Overview
 5.3 Prescription Drugs
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Prescription Drugs: Geographic Segmentation
 5.4 Over the Counter Drugs
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Over the Counter Drugs: Geographic Segmentation

Chapter 6: Pharmacy Retail Market by Distribution Channels
 6.1 Pharmacy Retail Market Overview Snapshot and Growth Engine
 6.2 Pharmacy Retail Market Overview
 6.3 Online
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Online: Geographic Segmentation
 6.4 Offline
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Offline: Geographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 Pharmacy Retail Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Pharmacy Retail Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 Pharmacy Retail Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 CVS HEALTH
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 ALBERTSONS COMPANIES
 7.4 AHOLD DELHAIZE
 7.5 THE JEAN COUTU GROUP (PJC) INC
 7.6 WALGREENS BOOTS ALLIANCE INC
 7.7 WELLNESS FOREVER PHARMACY
 7.8 DIRK ROSSMANN GMBH
 7.9 RITE AID CORP
 7.10 MEDPLUS HEALTH SERVICES PRIVATE LIMITED
 7.11 OTHER MAJOR PLAYERS

Chapter 8: Global Pharmacy Retail Market Analysis, Insights and Forecast, 2017-2032
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Drug Type
  8.2.1 Prescription Drugs
  8.2.2 Over the Counter Drugs
 8.3 Historic and Forecasted Market Size By Distribution Channels
  8.3.1 Online
  8.3.2 Offline

Chapter 9: North America Pharmacy Retail Market Analysis, Insights and Forecast, 2017-2032
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Drug Type
  9.4.1 Prescription Drugs
  9.4.2 Over the Counter Drugs
 9.5 Historic and Forecasted Market Size By Distribution Channels
  9.5.1 Online
  9.5.2 Offline
 9.6 Historic and Forecast Market Size by Country
  9.6.1 US
  9.6.2 Canada
  9.6.3 Mexico

Chapter 10: Eastern Europe Pharmacy Retail Market Analysis, Insights and Forecast, 2017-2032
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Drug Type
  10.4.1 Prescription Drugs
  10.4.2 Over the Counter Drugs
 10.5 Historic and Forecasted Market Size By Distribution Channels
  10.5.1 Online
  10.5.2 Offline
 10.6 Historic and Forecast Market Size by Country
  10.6.1 Bulgaria
  10.6.2 The Czech Republic
  10.6.3 Hungary
  10.6.4 Poland
  10.6.5 Romania
  10.6.6 Rest of Eastern Europe

Chapter 11: Western Europe Pharmacy Retail Market Analysis, Insights and Forecast, 2017-2032
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Drug Type
  11.4.1 Prescription Drugs
  11.4.2 Over the Counter Drugs
 11.5 Historic and Forecasted Market Size By Distribution Channels
  11.5.1 Online
  11.5.2 Offline
 11.6 Historic and Forecast Market Size by Country
  11.6.1 Germany
  11.6.2 UK
  11.6.3 France
  11.6.4 Netherlands
  11.6.5 Italy
  11.6.6 Russia
  11.6.7 Spain
  11.6.8 Rest of Western Europe

Chapter 12: Asia Pacific Pharmacy Retail Market Analysis, Insights and Forecast, 2017-2032
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Drug Type
  12.4.1 Prescription Drugs
  12.4.2 Over the Counter Drugs
 12.5 Historic and Forecasted Market Size By Distribution Channels
  12.5.1 Online
  12.5.2 Offline
 12.6 Historic and Forecast Market Size by Country
  12.6.1 China
  12.6.2 India
  12.6.3 Japan
  12.6.4 South Korea
  12.6.5 Malaysia
  12.6.6 Thailand
  12.6.7 Vietnam
  12.6.8 The Philippines
  12.6.9 Australia
  12.6.10 New Zealand
  12.6.11 Rest of APAC

Chapter 13: Middle East & Africa Pharmacy Retail Market Analysis, Insights and Forecast, 2017-2032
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Drug Type
  13.4.1 Prescription Drugs
  13.4.2 Over the Counter Drugs
 13.5 Historic and Forecasted Market Size By Distribution Channels
  13.5.1 Online
  13.5.2 Offline
 13.6 Historic and Forecast Market Size by Country
  13.6.1 Turkey
  13.6.2 Bahrain
  13.6.3 Kuwait
  13.6.4 Saudi Arabia
  13.6.5 Qatar
  13.6.6 UAE
  13.6.7 Israel
  13.6.8 South Africa

Chapter 14: South America Pharmacy Retail Market Analysis, Insights and Forecast, 2017-2032
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Drug Type
  14.4.1 Prescription Drugs
  14.4.2 Over the Counter Drugs
 14.5 Historic and Forecasted Market Size By Distribution Channels
  14.5.1 Online
  14.5.2 Offline
 14.6 Historic and Forecast Market Size by Country
  14.6.1 Brazil
  14.6.2 Argentina
  14.6.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. PHARMACY RETAIL MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. PHARMACY RETAIL MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. PHARMACY RETAIL MARKET COMPETITIVE RIVALRY
TABLE 005. PHARMACY RETAIL MARKET THREAT OF NEW ENTRANTS
TABLE 006. PHARMACY RETAIL MARKET THREAT OF SUBSTITUTES
TABLE 007. PHARMACY RETAIL MARKET BY DRUG TYPE
TABLE 008. PRESCRIPTION DRUGS MARKET OVERVIEW (2016-2030)
TABLE 009. OVER THE COUNTER DRUGS MARKET OVERVIEW (2016-2030)
TABLE 010. PHARMACY RETAIL MARKET BY DISTRIBUTION CHANNELS
TABLE 011. ONLINE MARKET OVERVIEW (2016-2030)
TABLE 012. OFFLINE MARKET OVERVIEW (2016-2030)
TABLE 013. NORTH AMERICA PHARMACY RETAIL MARKET, BY DRUG TYPE (2016-2030)
TABLE 014. NORTH AMERICA PHARMACY RETAIL MARKET, BY DISTRIBUTION CHANNELS (2016-2030)
TABLE 015. N PHARMACY RETAIL MARKET, BY COUNTRY (2016-2030)
TABLE 016. EASTERN EUROPE PHARMACY RETAIL MARKET, BY DRUG TYPE (2016-2030)
TABLE 017. EASTERN EUROPE PHARMACY RETAIL MARKET, BY DISTRIBUTION CHANNELS (2016-2030)
TABLE 018. PHARMACY RETAIL MARKET, BY COUNTRY (2016-2030)
TABLE 019. WESTERN EUROPE PHARMACY RETAIL MARKET, BY DRUG TYPE (2016-2030)
TABLE 020. WESTERN EUROPE PHARMACY RETAIL MARKET, BY DISTRIBUTION CHANNELS (2016-2030)
TABLE 021. PHARMACY RETAIL MARKET, BY COUNTRY (2016-2030)
TABLE 022. ASIA PACIFIC PHARMACY RETAIL MARKET, BY DRUG TYPE (2016-2030)
TABLE 023. ASIA PACIFIC PHARMACY RETAIL MARKET, BY DISTRIBUTION CHANNELS (2016-2030)
TABLE 024. PHARMACY RETAIL MARKET, BY COUNTRY (2016-2030)
TABLE 025. MIDDLE EAST & AFRICA PHARMACY RETAIL MARKET, BY DRUG TYPE (2016-2030)
TABLE 026. MIDDLE EAST & AFRICA PHARMACY RETAIL MARKET, BY DISTRIBUTION CHANNELS (2016-2030)
TABLE 027. PHARMACY RETAIL MARKET, BY COUNTRY (2016-2030)
TABLE 028. SOUTH AMERICA PHARMACY RETAIL MARKET, BY DRUG TYPE (2016-2030)
TABLE 029. SOUTH AMERICA PHARMACY RETAIL MARKET, BY DISTRIBUTION CHANNELS (2016-2030)
TABLE 030. PHARMACY RETAIL MARKET, BY COUNTRY (2016-2030)
TABLE 031. CVS HEALTH: SNAPSHOT
TABLE 032. CVS HEALTH: BUSINESS PERFORMANCE
TABLE 033. CVS HEALTH: PRODUCT PORTFOLIO
TABLE 034. CVS HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 034. ALBERTSONS COMPANIES: SNAPSHOT
TABLE 035. ALBERTSONS COMPANIES: BUSINESS PERFORMANCE
TABLE 036. ALBERTSONS COMPANIES: PRODUCT PORTFOLIO
TABLE 037. ALBERTSONS COMPANIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 037. AHOLD DELHAIZE: SNAPSHOT
TABLE 038. AHOLD DELHAIZE: BUSINESS PERFORMANCE
TABLE 039. AHOLD DELHAIZE: PRODUCT PORTFOLIO
TABLE 040. AHOLD DELHAIZE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 040. THE JEAN COUTU GROUP (PJC) INC: SNAPSHOT
TABLE 041. THE JEAN COUTU GROUP (PJC) INC: BUSINESS PERFORMANCE
TABLE 042. THE JEAN COUTU GROUP (PJC) INC: PRODUCT PORTFOLIO
TABLE 043. THE JEAN COUTU GROUP (PJC) INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. WALGREENS BOOTS ALLIANCE INC: SNAPSHOT
TABLE 044. WALGREENS BOOTS ALLIANCE INC: BUSINESS PERFORMANCE
TABLE 045. WALGREENS BOOTS ALLIANCE INC: PRODUCT PORTFOLIO
TABLE 046. WALGREENS BOOTS ALLIANCE INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. WELLNESS FOREVER PHARMACY: SNAPSHOT
TABLE 047. WELLNESS FOREVER PHARMACY: BUSINESS PERFORMANCE
TABLE 048. WELLNESS FOREVER PHARMACY: PRODUCT PORTFOLIO
TABLE 049. WELLNESS FOREVER PHARMACY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. DIRK ROSSMANN GMBH: SNAPSHOT
TABLE 050. DIRK ROSSMANN GMBH: BUSINESS PERFORMANCE
TABLE 051. DIRK ROSSMANN GMBH: PRODUCT PORTFOLIO
TABLE 052. DIRK ROSSMANN GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. RITE AID CORP: SNAPSHOT
TABLE 053. RITE AID CORP: BUSINESS PERFORMANCE
TABLE 054. RITE AID CORP: PRODUCT PORTFOLIO
TABLE 055. RITE AID CORP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. MEDPLUS HEALTH SERVICES PRIVATE LIMITED: SNAPSHOT
TABLE 056. MEDPLUS HEALTH SERVICES PRIVATE LIMITED: BUSINESS PERFORMANCE
TABLE 057. MEDPLUS HEALTH SERVICES PRIVATE LIMITED: PRODUCT PORTFOLIO
TABLE 058. MEDPLUS HEALTH SERVICES PRIVATE LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 059. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 060. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 061. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. PHARMACY RETAIL MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. PHARMACY RETAIL MARKET OVERVIEW BY DRUG TYPE
FIGURE 012. PRESCRIPTION DRUGS MARKET OVERVIEW (2016-2030)
FIGURE 013. OVER THE COUNTER DRUGS MARKET OVERVIEW (2016-2030)
FIGURE 014. PHARMACY RETAIL MARKET OVERVIEW BY DISTRIBUTION CHANNELS
FIGURE 015. ONLINE MARKET OVERVIEW (2016-2030)
FIGURE 016. OFFLINE MARKET OVERVIEW (2016-2030)
FIGURE 017. NORTH AMERICA PHARMACY RETAIL MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 018. EASTERN EUROPE PHARMACY RETAIL MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 019. WESTERN EUROPE PHARMACY RETAIL MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 020. ASIA PACIFIC PHARMACY RETAIL MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 021. MIDDLE EAST & AFRICA PHARMACY RETAIL MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 022. SOUTH AMERICA PHARMACY RETAIL MARKET OVERVIEW BY COUNTRY (2016-2030)